Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Clovis › NPI 1275751257
Clinic

Central Valley Indian Health, INC

Central Valley Indian Health, INC was paid $30.05M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 55% of everything it billed.

33Billing provider infoCENTRAL VALLEY INDIAN HEALTH, INC
CLOVIS, CA 93611
33aNPI1275751257assigned 04/23/2007
33bProvider typeClinic/Center
28Total paid$30.05M
24GClaims263,416
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in California

Rank by total paid#21 of 504
Median peer was paid$102K
This provider vs. median296×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,770$2.80M
201933,372$2.77M
202025,113$2.27M
202136,500$4.09M
202249,507$6.17M
202350,981$5.95M
2024incomplete42,173$6.01M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 55% 58,848 46,826 $16.66M
00003 Internal/system code - not a standard HCPCS code 43% 22,915 18,581 $12.78M
G0467 Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 1.3% 3,802 3,165 $392K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 51,394 43,515 $108K
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient <1% 1,681 1,142 $22K
0012A <1% 622 618 $20K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 7,384 6,533 $19K
0011A <1% 602 602 $13K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity <1% 9,937 9,181 $11K
0013A <1% 219 219 $9K
97803 <1% 776 595 $8K
97802 <1% 589 568 $3K
72 more codes
99203 Doctor's office visit, new patient (routine) <1% 1,002 $2K
36415 Collection of venous blood by venipuncture <1% 5,785 $867.58
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 5,552 $792.94
90688 <1% 1,123 $364.87
90832 Psychotherapy session, about 30 minutes <1% 110 $227.30
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 6,873 $196.37
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 32 $123.48
83036 Hemoglobin; glycosylated (A1C) <1% 4,464 $95.36
99173 <1% 5,672 $83.43
90715 <1% 1,326 $50.00
94760 <1% 1,887 $46.74
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,680 $37.50
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,339 $30.00
90686 <1% 1,722 $24.99
82962 <1% 4,139 $19.45
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,577 $17.70
90472 Immunization administration, each additional vaccine (list separately) <1% 2,119 $15.00
80061 Lipid panel <1% 13 $11.54
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 868 $7.33
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,480 $7.32
85018 <1% 4,780 $4.30
99000 <1% 6,783 $3.63
81002 <1% 3,021 $1.61
96110 Developmental screening, with scoring and documentation, per standardized instrument 0% 1,877 $0.00
99443 0% 1,580 $0.00
93000 0% 251 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 801 $0.00
99441 0% 8,980 $0.00
90480 0% 72 $0.00
G0008 Administration of influenza virus vaccine 0% 77 $0.00
90651 0% 451 $0.00
96127 0% 6,089 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 195 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 0% 355 $0.00
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 0% 55 $0.00
90619 0% 144 $0.00
99406 0% 682 $0.00
86580 0% 96 $0.00
90696 0% 58 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 94 $0.00
90723 0% 78 $0.00
90677 0% 28 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 84 $0.00
90680 0% 19 $0.00
90656 0% 120 $0.00
36416 0% 37 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 123 $0.00
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 0% 774 $0.00
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 0% 1,419 $0.00
92552 0% 3,047 $0.00
81025 0% 2,149 $0.00
99442 0% 3,987 $0.00
99215 Doctor's office visit, returning patient (complex) 0% 75 $0.00
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 0% 1,489 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 71 $0.00
90670 0% 401 $0.00
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 0% 1,240 $0.00
99204 Doctor's office visit, new patient (more involved) 0% 377 $0.00
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 0% 260 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 57 $0.00
90678 0% 13 $0.00
90662 0% 78 $0.00
90734 0% 160 $0.00
90633 0% 148 $0.00
90710 0% 49 $0.00
90714 0% 24 $0.00
90648 0% 58 $0.00
91322 0% 16 $0.00
90672 0% 12 $0.00
90750 0% 24 $0.00
90791 Psychiatric diagnostic evaluation 0% 13 $0.00
69209 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRAMSEY, JULIE (COO)
Same official

Other billing entities under RAMSEY, JULIE

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.